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Purpose: To evaluate the utility of oxygen challenge and report on temporal changes in blood oxygenation level-
dependent (BOLD) contrast in normal liver, hepatocellular carcinoma (HCC) and background fibrosis.
Materials and Methods: Eleven volunteers (nine male and two female, mean age 33.5, range 27–41 years) and 10
patients (nine male and one female, mean age 68.9, range 56–87 years) with hepatocellular carcinoma on a background
of diffuse liver disease were recruited. Imaging was performed on a 3T system using a multiphase, multiecho, fast gradi-
ent echo sequence. Oxygen was administered via a Hudson mask after 2 minutes of free-breathing. Paired t-tests were
performed to determine if the mean pre- and post-O2 differences were statistically significant.
Results: In patients with liver fibrosis (n5 8) the change in T2 following O2 administration was elevated (0.8860.582
msec, range 0.03–1.69 msec) and the difference was significant (P5 0.004). The magnitude of the BOLD response in
patients with HCC (n510) was larger, however the response was more variable (1.076 1.458 msec, range –0.93–3.26
msec), and the difference was borderline significant (P5 0.046). The BOLD response in the volunteer cohort was not sig-
nificant (P5 0.121, 0.5961.162 msec, range –0.81–2.44 msec).
Conclusion: This work demonstrates that the BOLD response following oxygen challenge within cirrhotic liver is consist-
ent with a breakdown in vascular autoregulatory mechanisms. Similarly, the elevated BOLD response within HCC is con-
sistent with the abnormal capillary vasculature within tumors and the arterialization of the blood supply. Our results
suggest that oxygen challenge may prove a viable BOLD contrast mechanism in the liver.
J. MAGN. RESON. IMAGING 2016;44:739–744.
Hepatocellular carcinoma (HCC) is the fifth most com-mon cancer and the third leading cause of cancer-
related death worldwide.1 The major clinical risk factors are
underlying chronic liver disease, typically secondary to viral
infections, nonalcoholic steatohepatitis, or chronic alcoholic
liver disease. Men are most commonly affected, with the
mean age of presentation 60 years.2
Several studies have investigated the utility of blood
oxygenation level-dependent (BOLD) contrast changes in
measuring oxygen perturbation within tumors. In 1997
Griffiths et al demonstrated that hyperoxic and hypercapnic
gas mixtures can change the deoxyhemoglobin fraction of
blood and act as a viable endogenous contrast mechanism
in a variety of tumor etiologies.3 Subsequent studies have
continued to hypothesize that autoregulatory function is
compromised in tumors as a result of chaotic vasculature
and abnormal smooth muscle cell development. The litera-
ture has focused on carbogen (95% O2 and 5% CO2)
3,4
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studies, thought to increase vasodilation within healthy tis-
sues, which alters the deoxy/oxyhemoglobin fraction and
induces BOLD signal intensity change in healthy tissue.
BOLD signal changes in response to carbogen are thought
to be more consistent than oxygen; however, carbogen stud-
ies have reported up to 30% aborted scans owing to subjects
experiencing “air hunger.”3,4 To mitigate this issue, investi-
gators have evaluated the utility of medical-grade oxygen to
induce a BOLD response; for example, Hallac et al used
oxygen and noted differences in BOLD responses between
cervical tumors and healthy tissue.5
HCC is often present on a background of diffuse liver
disease; however, only one study to date has explicitly inves-
tigated BOLD response as a function of liver fibrosis. Jin
et al used steady-state and dynamic carbogen challenges
with different diethylnitrosamine-induced liver fibrosis stages
to depict hemodynamic alterations during disease progres-
sion in a rat model.6 They found that both mean DR2
(r5 –0.773) and area of liver activation (r5 –0.691) were
inversely correlated with quantitative histopathological
assessment of the percentage liver fibrosis (P < 0.001). This
result warrants further investigation into BOLD contrast as
a marker of hepatic fibrosis.
The purpose of this study was to investigate the utility
of oxygen challenge at inducing a BOLD response in the
liver. This study reports the observed temporal changes in
T2 in healthy volunteers and compares this to patients with
HCC and background diffuse liver disease.
Materials and Methods
Study Design
This prospective single-center study was conducted following local
Research Ethics committee approval. All participants gave informed
written consent. Eleven healthy volunteers (nine male and two
female, mean age 33.5, range 27–41 years) with no history of hep-
atobiliary or cardiovascular disease and 10 patients (nine male and
one female, mean age 68.7, range 56–87 years) with a recent diag-
nosis of HCC were recruited. Four patients were diagnosed with
HCC after biopsy and the remaining six were diagnosed using
imaging following the EASL criteria (European Association for
Study of Liver).7 Eight out of 10 patients had background liver
fibrosis, which was diagnosed after biopsy (n5 7) or using imaging
criteria (n5 3). The underlying etiologies were established follow-
ing multidisciplinary review of biopsy, blood, and imaging data.
All participants fasted for a minimum of 8 hours prior to the
examination and had not undergone any tumor treatment.
Imaging Protocol
All the examinations were performed on a 3T whole-body magnetic
resonance imaging (MRI) system (Signa HDx, GE Healthcare,
Waukesha, WI). Participants were imaged feet first, supine, using
an 8-channel cardiac receive coil. A multiecho fast gradient echo
sequence was prescribed in a sagittal plane centered on the tumor.
The sequence acquired five slices each with 10 separate echoes,
with the following parameters: echo times (TEs)5 2.3/6.9/11.5–
43.7 msec; repetition time (TR)5 46 msec; flip angle5 158;
matrix size5 192 3 96; ASSET factor5 2; field of view
(FOV)5 35 cm; slice thickness5 8mm. The BOLD sequence was
modified to enable multiecho, multiphase operation with respira-
tory triggering using abdominal bellows. Each slice was acquired in
2.3 seconds. The BOLD protocol consisted of a 10-minute free-
breathing respiratory-triggered acquisition. Medical-grade oxygen
(BOC Healthcare, UK) was administered via a Hudson mask at
10 L/min after 2 minutes of free-breathing room air (Fig. 1). The
mask was left on for the duration of the scan. A dynamic contrast-
enhanced acquisition was also performed at the same slice location.
Image Analysis
In-house software was developed using MatLab (v. 8.3, Math-
Works, Natick, MA) to compute voxel-wise T2 maps from the
multiecho images at each temporal phase. The nonlinear Leven-
berg–Marquardt algorithm was used to compute T2 values after
initially seeding the fit with a log-linear approximation.
To account for residual differences in diaphragm position in
the respiratory-triggered acquisition, an affine transform was
applied to register each temporal phase. A rectangular mask was
used so that the rigid registration algorithm was optimal over the
area of interest. The image registration was performed by develop-
ing bespoke software in C11 that utilized the Insight Toolkit
(www.itk.org).
Regions of interest (ROIs) were defined on the spatially reg-
istered maps using in-house software developed in MatLab. ROIs
were defined to encompass background liver while excluding major
blood vessels and to delineate the hepatocellular carcinoma. ROIs
were defined by a radiologist (D.J.B.) with 4 years experience after
comparing comatched contrast enhanced images. The radiologist
also recorded the maximum diameter of each tumor.
Statistical Analysis
Mean T2 pre-O2 was computed by averaging the temporal phases
prior to O2 administration. Similarly, the mean T

2 post-O2 was
computed by averaging the temporal phases during O2 breathing,
acquired after a 3-minute delay to allow the BOLD effect to equi-
librate. Normality assumptions were formally assessed using a Sha-
piro–Wilk’s test. Paired t-tests were subsequently performed to
establish whether the differences between pre- and post-O2 T

2 val-
ues were significant. Student’s t-tests were also used to compare
native (pre-O2) T

2 in tumors against diffuse liver disease and
FIGURE 1: BOLD protocol: dynamic multiphase multiecho free-
breathing respiratory-triggered acquisition acquired pre- and
post-O2. Mean pre-O2 and mean post-O2 T

2 values were com-
pared after allowing a 3-minute transition period for the
response to equilibrate.
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healthy liver. P < 0.05 was defined as statistically significant. The
statistical analysis was performed using the R programming lan-
guage (v. 3.1.1, R Foundation for Statistical Computing, Vienna,
Austria).
Results
Etiologies for the patient cohort included nonalcoholic stea-
tohepatitis (n5 4), alcohol-related cirrhosis (n5 1), cirrhosis
following alpha-1 antitrypsin deficiency (n5 1), hepatitis B
(n5 1), and hepatitis C (n5 1); one patient developed a
spontaneous HCC and in one patient the etiology is
unknown. The mean of the maximum tumor diameters was
4.4 cm (range 1.8–7.5 cm).
All the volunteers and patients completed the BOLD
experiment. No datasets were excluded due to image quality
issues.
The change in T2 following the administration of O2
is summarized in Fig. 2 and Table 1. The change in T2 in
patients with confirmed liver fibrosis (n5 8) was consis-
tently elevated 0.886 0.582 msec, range (0.03–1.69 msec),
and the difference in T2 following O2 was statistically sig-
nificant (P5 0.004). The response in tumor tissue (n5 10)
was larger but also more variable 1.076 1.458 msec (range
–0.93–3.26 msec); the difference was borderline statistically
significant (P5 0.046). The change in T2 was also positive
following O2 administration in healthy volunteers (n5 11,
0.596 1.162 msec, range –0.81–2.44 msec); however, the
change was not significant (P5 0.121).
T2 of tumor pre-O2 (23.76 7.52 msec) was elevated
with respect to the patients’ background liver (15.26 5.84
msec), P5 0.01, and with respect to the volunteer liver
(17.16 3.71 msec), P5 0.025 (Fig. 3). The response to O2
is shown on a per-subject basis in Fig. 4.
Discussion
This study demonstrated the feasibility of assessing BOLD
contrast changes at 3T in response to oxygen challenge in
healthy and chronic diffuse liver disease, and within HCC.
We report a statistically significant elevation in T2 following
O2 administration in humans with confirmed liver fibrosis.
We also report elevated changes in HCC consistent with
Bane et al’s recent study that reported the feasibility and
test–retest variability of BOLD response in HCC using
both O2 and carbogen challenge at 1.5 and 3T.
8
In volunteers, no statistically significant change was
seen in response to 100% oxygen breathing, which is con-
sistent with previous reports measuring oxygen-induced T2
changes in the liver.9–11 Qualitatively, we observed that eight
responses remained close to the baseline signal, with T2 val-
ues in three volunteers appearing to elevate slowly over
time. Varying T2 responses to 100% oxygen challenge have
been reported in other healthy tissue types, indicating that
hyperoxia-induced changes in perfusion and oxygenation are
organ-specific.11 Blood flow to the liver is unique, given its
high vascularity and dual blood supply from the portal vein
and hepatic artery. Approximately 75% of total hepatic
blood flow is partially deoxygenated venous blood supplied
by the portal vein,12 which conducts blood from the stom-
ach, pancreas, small intestine, and spleen to the liver.
Increases in dissolved oxygen in arterial blood may therefore
FIGURE 2: Change in T2 following the administration of O2
illustrates comparative response in healthy liver tissue in nor-
mal volunteers against patients with diffuse liver disease and
within tumor tissue. The boxplots illustrate how response in
BOLD following O2 in diseased liver was consistently elevated
(0.8860.58, P50.004); the mean response within HCC was
larger, however, it was also more variable (1.0761.46,
P50.046).
TABLE 1. Change in T*2 in Response to O2
T2 (msec)
Pre O2 Post O2 Post-Pre O2 P-value
Patients Liver fibrosis (n5 8) 15.86 6.40 16.76 6.77 0.886 0.582 0.004
HCC (n5 10) 23.76 7.52 24.86 6.87 1.076 1.458 0.046
Volunteers Healthy liver (n5 11) 17.16 3.71 17.76 4.80 0.596 1.162 0.121
Mean6 SD.
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not be completely transmitted through portal circulation to
the liver; rather, the O2 status of the liver is partly dictated
by oxygen extraction in the gastrointestinal tract.13 Together,
these factors may explain the negligible change in T2 with
hyperoxia observed in healthy volunteers. Other studies have
shown that breathing pure oxygen may induce a slight vaso-
constriction in vessels,14 which coupled with a small increase
in the oxygenated hemoglobin fraction of venous blood may
cause the deoxygenated hemoglobin fraction within each
imaging voxel to decrease. This could account for the mod-
est T2 increase seen in three of our subjects.
Physiological response to carbogen differs from
response to 100% oxygen, as CO2 is a potent vasodilator.
In healthy liver tissue, perfusion is significantly increased in
response to hypercapnia.13,15 Tissue oxygenation generally
improves from augmented blood flow, but as most of the
increase occurs in the portal vein, there is an offset in
hepatic arterial flow, leading to an overall increase in the
ratio of deoxyhemoglobin to oxyhemoglobin. Highly signifi-
cant increases in R2 (51/T

2) have been found in healthy
liver in response to carbogen breathing,10,11,15 indicating
carbogen may be a useful stimulus. Bane et al recently per-
formed a systematic comparison of BOLD response in
HCC comparing oxygen and carbogen and found an ele-
vated BOLD response within HCC following oxygen chal-
lenge; however, the response to carbogen was not
significantly elevated.8 This suggests that the optimal stimuli
for BOLD liver examinations may need to be tailored
depending on the pathology of interest.
With the evolution of hepatic fibrosis, progressive dis-
ruption of normal liver architecture is seen, which gives rise
FIGURE 4: Temporal BOLD changes in T2 following O2 adminis-
tration. Change is T2 is plotted relative to the mean baseline
signal. The best-fit line is shown for the response post-O2 fol-
lowing a 3-minute transition period.
FIGURE 3: Absolute native T2 values (pre-O2) that illustrate
how T2 within HCC is significantly elevated with respect to
healthy liver (P50.025) and with respect to their diseased
background liver (P50.01).
Journal of Magnetic Resonance Imaging
742 Volume 44, No. 3
to regional and global changes in perfusion.16 Venous flow
typically decreases due to increased resistance in the portal
venous system, and may bypass the parenchyma completely
via portosystemic venous shunts.16 Hepatic arterial flow
commonly increases to counteract this effect. Impaired
hemodynamic response and increased arterial blood flow to
the liver may account for the elevated T2 response seen in
diseased liver tissue. This is consistent with a breakdown in
autoregulatory function, and is similar to the reduced hemo-
dynamic response to carbogen challenge observed by Jin
et al in their rat model of fibrosis.6
Measuring native T2 or change in T

2 (DT

2) in
response to a hyperoxic stimulus has been proposed as an
intrinsic marker of tumor oxygenation,17 as T2 is propor-
tional to the concentration of deoxyhemoglobin, which in
turn relates to arterial blood pO2. In this study we observed
a larger but more variable response to oxygen challenge in
HCC, which may be expected given variations in oxygen-
ation and perfusion, even within the same tumor type. The
initial pathogenesis of HCC involves an increased arterial
supply; however, in late-stage HCC the arterial blood supply
may decrease.18 This variability in blood supply, and the
consequent proportions of oxyhemoglobin, could be a
source of variability in the observed BOLD response.
We also observed that native tumor T2 (pre-O2) was
elevated with respect to both the patients’ background liver
and with respect to the volunteer liver. This supports obser-
vations that elevated baseline T2 can discriminate between
highly vascularized and avascular tumor types.19 However,
as evidenced by Jhaveri et al’s negative report of any correla-
tion between BOLD contrast and increased microvascular
invasion, this suggests that interpretation of the BOLD sig-
nal within tumors is complex.20
There were pragmatic issues noted when measuring T2
within HCC. In some cases, proximity of the tumor to the
lung could cause dephasing in the acquired images near the
air–tissue boundary, the very effect we were trying to mea-
sure. In this study two of the HCC patients had tumors
juxtapositional to lung. In this study we chose to include
these cases to evaluate the mean effect of HCC in patients,
given our sample size constraints.
Liver biopsy is the reference standard for diagnosis and
staging chronic liver disease, but it is an invasive procedure
with potential complications, and reproducibility is poor
due to the heterogeneity of fibrosis, small sample size, and
inter- and intraobserver variability in histologic assess-
ment.21 Alternative MR-based imaging techniques have
been proposed to noninvasively detect hepatic fibrosis,
including MR elastography,22 as well as conventional
diffusion-weighted MRI and contrast-enhanced methods.
These methods have been shown to have differing potential
in their diagnostic utility in diagnosis and grading of fibro-
sis, based on increased parenchymal stiffness, restricted water
diffusion, and associated alterations in perfusion patterns
with disease progression. Each of these respective methods is
at a different stage in terms of clinical acceptance; MR elas-
tography shows particular promise, in that stiffness has been
shown to linearly relate to fibrosis stage.22 In this context
the relationship between BOLD and fibrosis is unclear, and
subsequent studies will need to compare the BOLD
response to histopathological assessment of fibrosis grade in
humans.
BOLD, however, has the advantage that it is noninva-
sive and is based on an endogenous contrast mechanism.
Breathing oxygen was well tolerated by all subjects. In this
study we performed quantitative T2 measurements, rather
than simply measuring relative changes in T2-weighted sig-
nal intensity, which can be sensitive to blood flow via signal
intensity enhancement from unsaturated spins flowing into
the imaging plane. We also demonstrated that measuring
hepatic T2 is feasible at 3T using a respiratory-triggered,
free-breathing protocol, which enables dynamic measure-
ments over time. Measuring the BOLD effect at 3T should
be more sensitive than 1.5T to small perturbations in oxy-
genation, given the greater change in T2 for a proportional
change in the deoxyhemoglobin fraction.
Limitations of this study include sample size con-
straints. Greater significance could have been achieved with
a larger cohort; nevertheless, this exploratory study demon-
strates the feasibility of oxygen challenge for evaluating
healthy and diseased liver tissue and HCC. Lack of an age
match control group may lead to some bias in the results,
as volunteers were systematically younger than the patient
cohort. Future studies should consider acquiring more base-
line T2 maps pre-O2; this would allow quantification of
contrast repeatability and normal physiological variation.
Future studies should also consider applying novel
approaches that utilize the BOLD phenomena to assess vas-
omotor response.23
In conclusion, the BOLD response to oxygen chal-
lenge is a promising method for noninvasive diagnosis and
staging of chronic liver disease. The increase in T2 observed
within diffuse liver disease in response to hyperoxia is con-
sistent with a breakdown in vascular autoregulatory mecha-
nisms and an increased arterial fraction of flow. Similarly,
the elevated BOLD response within HCC is consistent with
the abnormal arterialized vasculature in tumors. Further
studies are needed to evaluate the benefit of measuring
BOLD response in HCC, particularly with respect to its
potential role as a biomarker of outcome and treatment
response.
Acknowledgment
Contract grant sponsor: Addenbrooke’s Charitable Trust;
Contract grant sponsor: Cambridge’s Experimental Cancer
Patterson et al.: BOLD Response in HCC
September 2016 743
Medicine Centre; Contract grant sponsor: NIHR compre-
hensive Biomedical Research Centre award to Cambridge
University Hospitals NHS Foundation Trust in partnership
with the University of Cambridge
This study was supported by the Addenbrooke’s Charitable
Trust and Cambridge’s Experimental Cancer Medicine
Centre which is joint funded by CRUK, NIHR England
and the Departments of Health in Scotland, Wales and
Northern Ireland. The study also received funding from a
NIHR comprehensive Biomedical Research Centre award to
Cambridge University Hospitals NHS Foundation Trust in
partnership with the University of Cambridge. We also wish
to thank the support of the MRIS unit staff.
References
1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden:
Globocan 2000. Int J Cancer 2001;94:153–156.
2. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular
carcinoma among patients with chronic liver disease. N Engl J Med
1993;328:1797–1801.
3. Griffiths JR, Taylor NJ, Howe FA, et al. The response of human tumors
to carbogen breathing, monitored by gradient-recalled echo magnetic
resonance imaging. Int J Radiat Oncol Biol Phys 1997;39:697–701.
4. Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human
tumor oxygenation during carbogen breathing. J Magn Reson Imag-
ing 2001;14:156–163.
5. Hallac RR, Ding Y, Yuan Q, et al. Oxygenation in cervical cancer and
normal uterine cervix assessed using blood oxygenation level-
dependent (BOLD) MRI at 3T. NMR Biomed 2012;25:1321–1330.
6. Jin N, Deng J, Chadashvili T, et al. Carbogen gas-challenge BOLD
MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis.
Radiology 2010;254:129–137.
7. EASL, EASL-EORTC clinical practice guidelines: management of hepa-
tocellular carcinoma. Eur J Cancer 2012;48:599–641.
8. Bane O, Besa C, Wagner M, et al. Feasibility and reproducibility of
BOLD and TOLD measurements in the liver with oxygen and carbogen
gas challenge in healthy volunteers and patients with hepatocellular
carcinoma. J Magn Reson Imaging 2015 doi: 10.1002/jmri.25051 [Epub
ahead of print].
9. Tadamura E, Hatabu H, Li W, et al. Effect of oxygen inhalation on
relaxation times in various tissues. J Magn Reson Imaging 1997;7:
220–225.
10. Winter JD, Estrada M, Cheng HL. Normal tissue quantitative T1 and
T2* MRI relaxation time responses to hypercapnic and hyperoxic
gases. Acad Radiol 2011;18:1159–1167.
11. O’Connor JP, Naish JH, Jackson A, et al. Comparison of normal tissue
R1 and R*2 modulation by oxygen and carbogen. Magn Reson Med
2009;61:75–83.
12. Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow:
the hepatic arterial buffer response revisited. World J Gastroenterol
2010;16:6046–6057.
13. Cheng HL. Effect of hyperoxia and hypercapnia on tissue oxygen and
perfusion response in the normal liver and kidney. PLoS One 2012;7:
e40485.
14. Crawford P, Good PA, Gutierrez E, et al. Effects of supplemental oxy-
gen on forearm vasodilation in humans. J Appl Physiol (1985) 1997;
82:1601–1606.
15. Barash H, Gross E, Matot I, et al. Functional MR imaging during
hypercapnia and hyperoxia: noninvasive tool for monitoring changes
in liver perfusion and hemodynamics in a rat model. Radiology 2007;
243:727–735.
16. Gulberg V, Haag K, Rossle M, et al. Hepatic arterial buffer response
in patients with advanced cirrhosis. Hepatology 2002;35:630–634.
17. Pacheco-Torres J, Lopez-Larrubia P, Ballesteros P, et al. Imaging
tumor hypoxia by magnetic resonance methods. NMR Biomed 2010;
24:1–16.
18. Asayama Y, Yoshimitsu K, Nishihara Y, et al. Arterial blood supply of
hepatocellular carcinoma and histologic grading: radiologic-
pathologic correlation. AJR Am J Roentgenol 2008;190:W28–34.
19. Park HJ, Kim YK, Min JH, et al. Feasibility of blood oxygenation level-
dependent MRI at 3T in the characterization of hepatic tumors.
Abdom Imaging 2014;39:142–152.
20. Jhaveri KS, Cleary SP, Fischer S, et al. Blood oxygen level-dependent
liver MRI: can it predict microvascular invasion in HCC? J Magn Reson
Imaging 2013;37:692–699.
21. Standish RA, Cholongitas E, Dhillon A, et al. An appraisal of
the histopathological assessment of liver fibrosis. Gut 2006;55:
569–578.
22. Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of
liver: technique, analysis, and clinical applications. J Magn Reson
Imaging 2013;37:544–555.
23. Rakow-Penner R, Daniel B, Glover GH. Detecting blood oxygen level-
dependent (BOLD) contrast in the breast. J Magn Reson Imaging
2009;32:120–129.
Journal of Magnetic Resonance Imaging
744 Volume 44, No. 3
